INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Form 4 transactions

66,723 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MK
MacNevin William K.EVP, Ops & Sustainability
SSRMSSR MINING INC.
Grant or award
A—
111 sh
Sep 11, 2026Sep 15, 2026
Page 336 of 1669
← PrevNext →
traded Sep 11, 2026
+4d
SEC Form 4

Evidence

9
AR
Antal RodneyDirector, Executive Chairman
SSRMSSR MINING INC.
Grant or award
A—
324 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
DM
Dugan MargaretChief Medical Officer
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
81.3K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

9
FR
Farnsworth RussellChief Accounting Officer
SSRMSSR MINING INC.
Grant or award
A—
15 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
SJ
Sparks Michael JohnChief Financial Officer
SSRMSSR MINING INC.
Grant or award
A—
70 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
MM
Mullen Laura MDirector
SSRMSSR MINING INC.
Grant or award
A—
10 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
SJ
Sparks Michael JohnChief Financial Officer
SSRMSSR MINING INC.
Grant or award
A—
22 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
SJ
Sparks Michael JohnChief Financial Officer
SSRMSSR MINING INC.
Grant or award
A—
106 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
BR
Booth Brian RDirector
SSRMSSR MINING INC.
Grant or award
A—
89 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
SJ
Sparks Michael JohnChief Financial Officer
SSRMSSR MINING INC.
Grant or award
A—
111 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
FE
Farid Fady Adel EdwardChief Strategy Officer
SSRMSSR MINING INC.
Grant or award
A—
107 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

9
WW
Weibel Paul Wesley IIIChief Executive Officer
FEAM5E Advanced Materials, Inc.
Option exercise
M—
383 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

9
FE
Farid Fady Adel EdwardChief Strategy Officer
SSRMSSR MINING INC.
Grant or award
A—
68 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

8
FK
Fleming KarenPRES, CMO ROSS DRESS FOR LESS
ROSTROSS STORES, INC.
Tax withholding
F$209K
907 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

8
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Open-market sale · 10b5-1 plan
SELL$6,100
100 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

6
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Option exercise
M—
125.0K sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
NV
Narayanadas VivekGeneral Counsel & Secretary
OKLOOklo Inc.
Option exercise
M—
210 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

5
CE
Cooper Jeffrey ElliottChief Financial Officer
GWREGuidewire Software, Inc.
Option exercise
M—
37.8K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

5
BB
Ball BryanSee remarks
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
91.6K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$27K
13.8K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

5
MN
Mesa NildaDirector
UTHRUNITED THERAPEUTICS Corp
Option exercise
M$14K
130 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

5
HJ
Hanson JohnChief of Staff
OKLOOklo Inc.
Option exercise
M—
961 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
RA
Renner AlexandraChief Product Officer
OKLOOklo Inc.
Option exercise
M—
1,202 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
BB
Ball BryanSee remarks
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
91.6K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

5
HJ
Hanson JohnChief of Staff
OKLOOklo Inc.
Option exercise
M—
961 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
MN
Mesa NildaDirector
UTHRUNITED THERAPEUTICS Corp
Option exercise
M—
130 sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

5
RA
Renner AlexandraChief Product Officer
OKLOOklo Inc.
Option exercise
M—
1,202 sh
Sep 13, 2026Sep 15, 2026
traded Sep 13, 2026
+2dSEC Form 4

Evidence

5
NV
Narayanadas VivekGeneral Counsel & Secretary
OKLOOklo Inc.
Option exercise
M—
210 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

5
MP
Mullen John PPresident
GWREGuidewire Software, Inc.
Option exercise
M—
75.2K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

4
PL
Phillips Ronald LEVP and CHRO
SYYSYSCO CORP
Open-market sale · 10b5-1 plan
SELL$80K
960 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

3
AM
Abernethy MattChief Financial Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award · 10b5-1 plan
A—
5,020 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

3
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M$24K
18.0K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

3
BW
Boyer David W.Chief Corp. Affairs Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award · 10b5-1 plan
A—
3,587 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

2
CC
Chen Sean ChihhsiangPresident and COO
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M$122K
15.0K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

2
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Option exercise
M—
123.1K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

2
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
194.0K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

2
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
194.0K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC Form 4

Evidence

2
DS
Dotan SaarEVP Countries & BD
ZIMZIM Integrated Shipping Services Ltd.
Option exercise
M—
22.4K sh
Sep 14, 2026Sep 15, 2026
traded Sep 14, 2026
+1dSEC Form 4

Evidence

2
EF
Esaka FumihideDirector, Chief Executive Officer
AMBQAmbiq Micro, Inc.
Option exercise · 10b5-1 plan
M$630K
50.0K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

2
HJ
Higgins JackChief Scientific Officer
IMNMImmunome Inc.
Gift · 10b5-1 plan
G—
8,800 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K